NCT06522789

Brief Summary

This study aims to determine if objective markers describing corneal optical density (COD), thinnest corneal thickness (TCT), anterior (ARC), and posterior (PRC) surface radii over the 3mm thinnest region of the cornea could provide a model for calculating corrected distance visual acuity (CDVA) after corneal cross-linking (CXL) in keratoconus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 26, 2024

Completed
Last Updated

July 30, 2024

Status Verified

July 1, 2024

Enrollment Period

4.3 years

First QC Date

July 22, 2024

Last Update Submit

July 28, 2024

Conditions

Keywords

Keratoconuscross-linkingcorneal optical density

Outcome Measures

Primary Outcomes (2)

  • Association between preoperative corneal characteristics derived by Pentacam and subjective parameter CDVA and postoperative CDVA at the end of the follow-up period

    Associations between Corneal Optical Density, Thinnest Corneal Thickness, Anterior Radius Curvature (ARC), Posterior Radius Curvature (PRC), ARC/PRC ratio, CDVA values at the start of the study and CDVA at postoperative.

    one year

  • Associations between predicted and actual CDVA following CXL

    The differences in the mean predicted values measured at six months and one year.

    one year

Secondary Outcomes (3)

  • Corrected Distance Visual Acuity (CDVA) changes in all three groups during the follow up

    one year

  • Corneal Optical Density (COD) changes in all three groups during the follow up

    one year

  • Corneal thickness (TCT) changes in all three groups during the follow up.

    one year

Study Arms (3)

Group 1

ACTIVE COMPARATOR

The total number of patients who underwent CXL was seventy-seven; 23 were females, and 54 were males of the mean (±sd, range) age 24.2 (±7.0, 11-44) years.

Procedure: corneal cross-linking procedure

Group 2

NO INTERVENTION

Twenty-three patients, six females and 17 males of mean age 27.3 (±7.0, 17-44) years, were untreated.

Group 3

NO INTERVENTION

Twenty-four subjects, nine females and 15 males of mean age 24.7 (±7.6, 17-45) years, were recruited as controls.

Interventions

Standard Dresden protocol corneal cross-linking procedure The CXL procedure adhered to the standard Dresden protocol. All patients received topical anaesthetic (Tetracaine HCL 0.5%, Alcon Forth Worth, Texas) and a miotic (Isopto Carpine 2% HCl, Alcon, Fort Worth, Texas) drops 30 minutes before the procedure. The periocular region and conjunctival sac were washed with 10% povidone-iodine (Betadine 10%, Alcaloid, Skopje). Manual epithelial scraping with a crescent knife followed. Pachymetry was kept over 400 μm during the procedure and measured with an ultrasound hand pachymeter (Pocket II, Quantel Medical, Cournon d'Auvergne, France). Riboflavin (Peschke D, Peschke Trade, Huenenberg, Switzerland) was applied every 3 minutes for 30 minutes. We performed corneal UV-A radiation with a wavelength of 370 nm and energy of 3mW using a UVA CXL lamp (VEGA CBM-X-Linker, Carleton Optical, Chesham, UK) for 30 minutes (6 cycles of 5 minutes each).

Group 1

Eligibility Criteria

Age11 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Group 1 consisted of cases in which the astigmatism had increased by 1D or more, according to subjective refraction and corneal surface topography, over the previous year.
  • Group 2 subjects consisted of confirmed keratoconus without signs of progression who opted to continue with their prescription glasses and tear-enhancing drops where necessary
  • Group 3 is a control group of age- and gender-matched individuals without signs of keratoconus.

You may not qualify if:

  • prior corneal surgeries, pachymetry less than 400 microns, scars or cloudings of the cornea, chemical injuries, severe dry eye, delayed epithelial healing and any inflammatory eye surface process before the CXL procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fanka Gilevska

Skopje, 1000, North Macedonia

Location

Related Publications (1)

  • Gilevska F, Biscevic A, Bohac M, Patel S. Could Automated Objective Measurements Acquired at the Preoperative Stage Estimate the Corrected Distance Visual Acuity after Corneal Cross-Linking in Keratoconus? Ophthalmol Ther. 2024 Oct;13(10):2599-2614. doi: 10.1007/s40123-024-00993-0. Epub 2024 Aug 7.

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Fanka Gilevska, PhD cand

    Sistina Ophthalmology Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 22, 2024

First Posted

July 26, 2024

Study Start

April 1, 2018

Primary Completion

July 30, 2022

Study Completion

July 30, 2023

Last Updated

July 30, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations